Government
Every published round U.S. Government took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
Companies U.S. Government has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| No portfolio companies recorded yet. | ||||
Fund closes reported for U.S. Government, as distinct from the investments it has made.
Companies U.S. Government has backed that another company then bought. An exit for the holding, not a deal U.S. Government did.
Stories naming U.S. Government. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Melbourne biotech ENA Respiratory has begun dosing participants in the second part of its Phase IIa trial of INNA-051; its investor lineup, past government funding awards and BLUE KNIGHT alumni status are recapped.
Melbourne-based ENA Respiratory announced US patent allowances covering its TLR2 agonist platform and a COPD treatment method, strengthening IP protection for its INNA-051 nasal spray candidate now in Phase II testing.
Melbourne biotech ENA Respiratory has begun dosing volunteers in a mid-stage trial of its INNA-051 antiviral spray, aimed at limiting common viral illnesses in at-risk groups.
A news roundup covering a government-backed hydrogen project for Telstra, a climate tech fund's first close, new appointments at a South Australian agency and a feed company, plus export approvals and science prizes.
Also @AuManufacturing